Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Propensity score-matched study of laparoscopic and open surgery for colorectal cancer in rural hospitals.

Nakao T, Shimada M, Yoshikawa K, Higashijima J, Tokunaga T, Nishi M, Takasu C, Kashihara H, Suzuka I, Nishizaki T, Okitsu H, Yagi T, Miyake H, Miura M, Fukuyama M, Wada D, Bando Y.

J Gastroenterol Hepatol. 2016 Oct;31(10):1700-1704. doi: 10.1111/jgh.13322.

PMID:
26896303
2.

Cutaneous carcinosarcoma: a series of six cases and a review of the literature.

Clark JJ, Bowen AR, Bowen GM, Hyngstrom JR, Hadley ML, Duffy K, Florell SR, Wada DA.

J Cutan Pathol. 2016 Oct 11. doi: 10.1111/cup.12843. [Epub ahead of print]

PMID:
27730657
3.

Vibration monitoring of a helicopter blade model using the optical fiber distributed strain sensing technique.

Wada D, Igawa H, Kasai T.

Appl Opt. 2016 Sep 1;55(25):6953-9. doi: 10.1364/AO.55.006953.

PMID:
27607270
4.

Efficacy of erlotinib and imatinib in a patient with a rectal gastrointestinal stromal tumor and synchronous pulmonary adenocarcinoma: A case report.

Miyoshi T, Mori R, Amano S, Sumitomo H, Aoyama M, Inoue S, Hino N, Wada D.

J Med Invest. 2016;63(1-2):144-8. doi: 10.2152/jmi.63.144.

PMID:
27040071
5.
6.

Population pharmacokinetic/pharmacodynamic modeling of tumor growth kinetics in medullary thyroid cancer patients receiving cabozantinib.

Miles DR, Wada DR, Jumbe NL, Lacy SA, Nguyen LT.

Anticancer Drugs. 2016 Apr;27(4):328-41. doi: 10.1097/CAD.0000000000000330.

PMID:
26825867
7.

Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9.

Budha NR, Leabman M, Jin JY, Wada DR, Baruch A, Peng K, Tingley WG, Davis JD.

AAPS J. 2015 Jul;17(4):881-90. doi: 10.1208/s12248-015-9750-8.

8.

Chronic, Painful, Nonhealing Ulcer on the Right Arm Following Minor Trauma.

Hawkes JE, Florell SR, Wada DA.

JAMA Dermatol. 2015 Jul;151(7):787-8. doi: 10.1001/jamadermatol.2014.5373. No abstract available.

PMID:
25785574
9.

Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course.

Chavan RN, Bridges AG, Knudson RA, Ketterling RP, Comfere N, Wada DA, Torres-Cabala C, DiCaudo DJ, Vasmatzis G, Pittelkow MR, Feldman AL.

Blood Cancer J. 2014 Oct 17;4:e253. doi: 10.1038/bcj.2014.73. No abstract available.

10.

Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat.

Kurata T, Lukic V, Kozuki M, Wada D, Miyazaki K, Morimoto N, Ohta Y, Deguchi K, Ikeda Y, Kamiya T, Abe K.

J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2580-90. doi: 10.1016/j.jstrokecerebrovasdis.2014.05.023.

PMID:
25241340
11.

Neutrophilic sebaceous adenitis with intralobular Demodex mites: a case report and review of the literature.

Liaqat M, Wilson LH, Wada D, Florell SR, Bowen AR.

Am J Dermatopathol. 2015 Apr;37(4):315-8. Review.

PMID:
25229566
12.

Adequacy of 5-mm surgical excision margins for non-lentiginous melanoma in situ.

Duffy KL, Truong A, Bowen GM, Andtbacka RH, Hyngstrom J, Bowles T, Grossmann K, Khong H, Hyde M, Florell SR, Bowen AR, Wada D, Grossman D.

J Am Acad Dermatol. 2014 Oct;71(4):835-8. doi: 10.1016/j.jaad.2014.06.044. No abstract available.

13.

Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors.

Garg A, Quartino A, Li J, Jin J, Wada DR, Li H, Cortés J, McNally V, Ross G, Visich J, Lum B.

Cancer Chemother Pharmacol. 2014 Oct;74(4):819-29. doi: 10.1007/s00280-014-2560-3.

PMID:
25119184
14.

Signal processing method based on group delay calculation for distributed Bragg wavelength shift in optical frequency domain reflectometry.

Wada D, Igawa H, Murayama H, Kasai T.

Opt Express. 2014 Mar 24;22(6):6829-36. doi: 10.1364/OE.22.006829.

PMID:
24664031
15.

Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization.

Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, Gibson LE.

J Am Acad Dermatol. 2014 Jun;70(6):1021-7. doi: 10.1016/j.jaad.2014.01.874.

PMID:
24636890
16.

Primary cutaneous follicle centre lymphoma presenting as diffuse facial erythema.

Wada C, Glenn MJ, Hyde M, Powell DL, Miles RR, Duffy K, Florell SR, Wada DA.

J Eur Acad Dermatol Venereol. 2015 Apr;29(4):825-6. doi: 10.1111/jdv.12430. No abstract available.

PMID:
24628872
17.

GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.

Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA.

Blood. 2014 May 8;123(19):3007-15. doi: 10.1182/blood-2013-12-544809.

18.

Long-term effect of telmisartan on Alzheimer's amyloid genesis in SHR-SR after tMCAO.

Kurata T, Lukic V, Kozuki M, Wada D, Miyazaki K, Morimoto N, Ohta Y, Deguchi K, Yamashita T, Hishikawa N, Matsuzono K, Ikeda Y, Kamiya T, Abe K.

Transl Stroke Res. 2015 Apr;6(2):107-15. doi: 10.1007/s12975-013-0321-y.

PMID:
24435631
19.

Impact on survival of whole-body computed tomography before emergency bleeding control in patients with severe blunt trauma.

Wada D, Nakamori Y, Yamakawa K, Yoshikawa Y, Kiguchi T, Tasaki O, Ogura H, Kuwagata Y, Shimazu T, Hamasaki T, Fujimi S.

Crit Care. 2013 Aug 27;17(4):R178. doi: 10.1186/cc12861.

20.

CD4⁺CD25⁺FOXP3⁺ malignant T cells in Sézary syndrome are not necessarily functional regulatory T cells.

Wada DA, Pittelkow MR, Comfere NI, Gibson LE, Ansell SM, Wilcox RA.

J Am Acad Dermatol. 2013 Sep;69(3):485-9. doi: 10.1016/j.jaad.2010.01.013. No abstract available.

PMID:
23957976
Items per page

Supplemental Content

Support Center